Log In
Print
BCIQ
Print
Print this Print this
 

Agenmestencel-T, MSC_apceth_101

  Manage Alerts
Collapse Summary General Information
Company Apceth GmbH & Co. KG
DescriptionHuman autologous, bone-marrow derived mesenchymal stem cells
Molecular Target
Mechanism of Action 
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase I/II
Standard IndicationGastric cancer
Indication DetailsTreat advanced adenocarcinomas of the gastrointestinal tract
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today